Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis

Breast cancer treatment remains challenging due to high levels of cell metastasis. Chemotherapy drug combinations can inhibit both tumor growth in situ and metastasis to distant organs. Therefore, here, we developed chondroitin sulfate liposomes (CSLs) as a carrier for the co-delivery of retinoic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhiwei, Ma, Lixin, Luo, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003575/
https://www.ncbi.nlm.nih.gov/pubmed/33808649
http://dx.doi.org/10.3390/pharmaceutics13030406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003575/
https://www.ncbi.nlm.nih.gov/pubmed/33808649
http://dx.doi.org/10.3390/pharmaceutics13030406

Ejemplares similares